Worth reading
51Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
2
Year-on-year decrease in operating income (¥100 million)Wording
Conditional
How definitive the wording is.Contents of this document
Earnings presentation materialsSecond quarter of the fiscal year ending March 20277 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥37.3 100 million+1.0%
Operating profit¥5.6 100 million-26.0%
Ordinary income¥6.7 100 million-18.0%
Net income¥6.7 100 million-8.0%
Operating profit margin12.2 %
Results for the three months of the current quarter
Business Produce sales
¥18.1 100 million
Full-year earnings forecast
Business Produce sales
75 or more
Business Produce operating income
5 or more
Venture Investment salesNot disclosed
Venture Investment operating incomeNot disclosed
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Business Produce sales
46 %
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
The Business Produce business is progressing smoothly toward achieving its full-year plan. On track against the five-year targets.New initiatives
- Launch of a joint integrated digital platform business in India with DENSO CORPORATION
- Capital and business alliance with UMI in the GX and materials chemistry fields
- Continued participation in the second phase of Toyota City's preventive care business
- Strengthening the development of business producers and reviewing recruitment policies
Key KPIsA metric the company considers important as a management benchmark.
- Number of business producers176 people
- Contracted sales (recognized in the current fiscal year)¥38.4 100 million
- Cumulative participants in the preventive care business3.7 10,000 people
- Unrealized gains on venture investments¥3 100 million
Segment results
Business Produce
Net Sales
¥34.8 100 million+20.0%
Operating profit
¥4.2 100 million+37.0%
Venture Investment
Net Sales
¥2.4 100 million-69.0%
Operating profit
¥1.4 100 million-69.0%
Medium-term management plan targets
Target fiscal yearFiscal year ending March 2030
Business Produce sales¥11 billion or more
Business Produce operating income¥1.7 billion or more, with an operating margin of 15% or more
Comparison with actual resultsFiscal year ended March 2026 results: sales of ¥6.7 billion and operating income of ¥800 million
Number of employees
Number of Employees222 people
Change during the periodBusiness producers increased by 17 from the end of the previous fiscal year
Annual Dividend
Annual Dividend¥137 per share
Year-end dividend137
| Item | Details |
|---|---|
| Document type | Earnings presentation materials |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | ¥37.3 100 million (YoY +1.0%) |
| Operating profit | ¥5.6 100 million (YoY -26.0%) |
| Ordinary income | ¥6.7 100 million (YoY -18.0%) |
| Net income | ¥6.7 100 million (YoY -8.0%) |
| Operating profit margin | 12.2 % |
| Results for the three months of the current quarter | Business Produce sales ¥18.1 100 million |
| Full-year earnings forecast | Business Produce sales 75 or more / Business Produce operating income 5 or more / Venture Investment sales Not disclosed / Venture Investment operating income Not disclosed |
| Progress against full-year forecast | Business Produce sales 46 % |
| Self-assessment against the plan | The Business Produce business is progressing smoothly toward achieving its full-year plan. On track against the five-year targets. |
| Segment results | Business Produce Net Sales ¥34.8 100 million (YoY +20.0%) / Operating profit ¥4.2 100 million (YoY +37.0%) / Venture Investment Net Sales ¥2.4 100 million (YoY -69.0%) / Operating profit ¥1.4 100 million (YoY -69.0%) |
| Key KPIs | Indicator name Number of business producers / Value 176 people / Year on year against the same period last year Not disclosed, Indicator name Contracted sales (recognized in the current fiscal year) / Value ¥38.4 100 million / Year on year against the same period last year Not disclosed, Indicator name Cumulative participants in the preventive care business / Value 3.7 10,000 people / Year on year against the same period last year Not disclosed, Indicator name Unrealized gains on venture investments / Value ¥3 100 million / Year on year against the same period last year Not disclosed |
| Number of employees | Number of Employees 222 people / Change during the period Business producers increased by 17 from the end of the previous fiscal year |
| Medium-term management plan targets | Target fiscal year Fiscal year ending March 2030 / Business Produce sales ¥11 billion or more / Business Produce operating income ¥1.7 billion or more, with an operating margin of 15% or more / Comparison with actual results Fiscal year ended March 2026 results: sales of ¥6.7 billion and operating income of ¥800 million |
| Annual Dividend | Annual Dividend ¥137 per share / Interim Dividend Not disclosed / Year-end dividend 137 |
| New initiatives | Launch of a joint integrated digital platform business in India with DENSO CORPORATION, Capital and business alliance with UMI in the GX and materials chemistry fields, Continued participation in the second phase of Toyota City's preventive care business, Strengthening the development of business producers and reviewing recruitment policies |
Items this document does not state (14)
Gross Profit MarginSelling, general and administrative expensesBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of stores and locationsAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookFinancial targetsPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Business Produce business reported higher sales and profit, driven by corporate transformation and DX demand, growth in long-term projects, an increase in repeat customers, and expansion in the T&A area. The Venture Investment business declined from the previous year due to partial sales following the IPO of an Indian portfolio company, income from funds in which the company has invested, and impairment losses.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.